Driven by the strong recovery in hearing healthcare market and robust demand for its communications solutions, Demant returned to growth in H2 20, though sales were below the normal level. Interestingly, strict cost management bolstered profitability as well. Assuming the hearing market normalises in H1 21, management has set ambitious but risky targets for FY21 – pent-up demand for hearing solutions and the recently-launched Oticon More should be the key growth contributors. The DKK2bn share bu ....
10 Feb 2021
Pent-up demand visible in H2 20; ambitious guidance for FY21
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Pent-up demand visible in H2 20; ambitious guidance for FY21
- Published:
10 Feb 2021 -
Author:
Sumit Sayal -
Pages:
5
Driven by the strong recovery in hearing healthcare market and robust demand for its communications solutions, Demant returned to growth in H2 20, though sales were below the normal level. Interestingly, strict cost management bolstered profitability as well. Assuming the hearing market normalises in H1 21, management has set ambitious but risky targets for FY21 – pent-up demand for hearing solutions and the recently-launched Oticon More should be the key growth contributors. The DKK2bn share bu ....